Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis

BACKGROUND: Intravenous thrombolysis using recombinant tissue plasminogen activator remains the mainstay treatment of acute ischemic stroke (AIS), although endovascular treatment is becoming standard of care in case of large vessel occlusions (LVO). To quantify the thrombus burden in LVO, a semiquan...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Szegedi, István, Orbán-Kálmándi, Rita, Nagy, Attila, Sarkady, Ferenc, Vasas, Nikolett, Sik, Máté, Lánczi, Levente István, Berényi, Ervin, Oláh, László, Crișan, Alexandra, Csiba, László, Bagoly, Zsuzsa
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2021
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8263307/
https://ncbi.nlm.nih.gov/pubmed/34234378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0254253
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak